Cambria Investment Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$231K Sell
2,682
-602
-18% -$54K 0.01% 603
2025
Q4
$287K Buy
+3,284
New +$249K 0.02% 518
2025
Q3
Sell
-3,434
Closed -$203K 545
2025
Q2
$203K Hold
3,434
0.01% 425
2025
Q1
$251K Buy
+3,434
New +$284K 0.02% 327

Other funds holding GMED

Cambria Investment Management's GMED Position: Q1 2026 in Review

Cambria Investment Management reduced its Globus Medical (GMED) stake by 18% in Q1 2026, selling an estimated $54K and leaving 2,682 shares worth $231K. The position accounts for 0.01% of the portfolio, ranked #603.

Cambria Investment Management first reported a position in GMED in Q1 2025 and has held it in 4 quarters since. The position peaked at $287K in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Cambria Investment Management held 2,682 shares of Globus Medical worth $231K as of Q1 2026.
  • Cambria Investment Management sold 602 Globus Medical shares in Q1 2026, an estimated $54K.
  • Globus Medical made up 0.01% of Cambria Investment Management's portfolio in Q1 2026, its #603 holding.
  • Cambria Investment Management first reported a position in Globus Medical in Q1 2025 and has held it in 4 quarters since.
  • Cambria Investment Management's Globus Medical position peaked at $287K in Q4 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Cambria Investment Management's 13F filing for Q1 2026, filed 15 May 2026.